EN
| Apr. | Date: | Wednesday, April 18, 2018. from 12:00 to 14:00. |
|---|---|---|
| Place: | Tokyo American Club（TAC） www.tokyoamericanclub.org |
|
| Topic: | Antibody agent, Aducanumab, for Alzheimer’s disease and A first Antisense. Oligonucleotide (ASO) therapy, Nusinersen, for SMA |
|
| Speaker: | Mr. Shinichi Torii, Ph.D., President and Representative Director, Biogen Japan Ltd. |
|
| Fee: | Visitor Fees are payable at the door - Visitor from company of Pharma Delegates member: JPY 12,000 - Visitor from company which is not Pharma Delegates member: JPY 15,000 Cancelation Policy for Non-member and Visitor from Member Company: -Before 10:00 am, on Monday, 16 Apr. 2018 : No Charge -After 10:00 am, on Monday, 16 Apr. 2018 : 100% charge -No-shows on the day : 100% charge |
EN